On 26 March 2021 a ‘Dear CEO‘ letter was published clearly stating the supervisory focus on new £ LIBOR2 milestones. So, for those out there still trading £ LIBOR, this letter might be worth a read: the ‘interesting’ part is in the annex – so scroll right down.
by end Q1 2021, cease initiation of new GBP LIBOR-linked loans, bonds, securitisations and linear derivatives* that expire after the end of 2021
(* Except for risk management of existing positions)
It’s clear this is serious:
“Firms should have robust processes in place to ensure that all new sterling LIBOR business is closely controlled, and the use of the linear derivative risk management exemption is consistent with its express purpose of facilitating the risk management of existing positions. Any incident of sterling LIBOR-referencing loan, bond or securitisation issuance from Thursday 1 April onwards that expires beyond end- 2021 would potentially be viewed as indicative of poor risk management and poor governance of transition.
What if you are not ready?
There has been some debate in the market as to the extent to which these milestones across linear derivatives and loans would be enforced. Even if some of the excuses may seem valid e.g. end users not being ready, the annex isn’t suggesting much sympathy, going on to state:
“In a situation where end-user readiness for use of RFR-based alternatives is not yet in place, we note that alternative funding solutions exist which would be consistent with the milestones of the RFRWG, such as the use of a fixed rate, an alternative floating rate or a short-term LIBO0R-linked facility that expires before the end of 2021.”
The letter also goes on to remind us of the importance of active transition:
“We expect firms to intensify efforts to execute plans to transition the stock of legacy LIBOR-linked contracts ahead of confirmed cessation dates of panel bank LIBOR, wherever it is feasible to do so”
The letter covers a range of factors around ending £ LIBOR however what we’re all approaching very soon is a hard stop for £ LIBOR loans and hard(ish) stop for £ derivatives.
Still want more?
On 30 March we hosted a short webinar at which we talked through the Q1 milestones and contextualized developments in the busy end game for LIBOR. Click here to watch the replay.
This article has been prepared for information purposes only, does not constitute an analysis of all potentially material issues and is subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes. It is indicative only and is not binding. Other than as indicated, this article has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty, undertaking or assurance of any kind, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of the information contained in this article, nor does NatWest Markets accept any obligation to any recipient to update or correct any information contained herein. Views expressed herein are not intended to be and should not be viewed as advice or as a personal recommendation. The views expressed herein may not be objective or independent of the interests of the authors or other NatWest Markets trading desks, who may be active participants in the markets, investments or strategies referred to in this article. NatWest Markets will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser; nor does NatWest Markets owe any fiduciary duties to you in connection with this, and/or any related transaction and no reliance may be placed on NatWest Markets for investment advice or recommendations of any sort. You should make your own independent evaluation of the relevance and adequacy of the information contained in this article and any issues that are of concern to you.
This article does not constitute an offer to buy or sell, or a solicitation of an offer to buy or sell any investment, nor does it constitute an offer to provide any products or services that are capable of acceptance to form a contract. NatWest Markets and each of its respective affiliates accepts no liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this material or reliance on the information contained herein. However this shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not be lawfully disclaimed.
NatWest Markets Plc. Incorporated and registered in Scotland No. 90312 with limited liability. Registered Office: 36 St Andrew Square, Edinburgh EH2 2YB. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority. NatWest Markets N.V. is incorporated with limited liability in the Netherlands, authorised and regulated by De Nederlandsche Bank and the Autoriteit Financiële Markten. It has its seat at Amsterdam, the Netherlands, and is registered in the Commercial Register under number 33002587. Registered Office: Claude Debussylaan 94, Amsterdam, the Netherlands. Branch Reg No. in England BR001029. NatWest Markets Plc is, in certain jurisdictions, an authorised agent of NatWest Markets N.V. and NatWest Markets N.V. is, in certain jurisdictions, an authorised agent of NatWest Markets Plc. NatWest Markets Securities Japan Limited [Kanto Financial Bureau (Kin-sho) No. 202] is authorised and regulated by the Japan Financial Services Agency. Securities business in the United States is conducted through NatWest Markets Securities Inc., a FINRA registered broker-dealer (http://www.finra.org), a SIPC member (www.sipc.org) and a wholly owned indirect subsidiary of NatWest Markets Plc.